These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22339456)

  • 1. Conference scene: immune effector mechanisms in tumor immunity.
    Sikora AG; Hailemichael Y; Overwijk WW
    Immunotherapy; 2012 Feb; 4(2):141-3. PubMed ID: 22339456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T regulatory cells in cancer: recent advances and therapeutic potential.
    Elkord E; Alcantar-Orozco EM; Dovedi SJ; Tran DQ; Hawkins RE; Gilham DE
    Expert Opin Biol Ther; 2010 Nov; 10(11):1573-86. PubMed ID: 20955112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling defects in anti-tumor T cells.
    Frey AB; Monu N
    Immunol Rev; 2008 Apr; 222():192-205. PubMed ID: 18364003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells: a critical player in cancer therapy?
    Palucka AK; Ueno H; Fay J; Banchereau J
    J Immunother; 2008; 31(9):793-805. PubMed ID: 18833008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing immune responses to tumor-associated antigens.
    Higgins JP; Bernstein MB; Hodge JW
    Cancer Biol Ther; 2009 Aug; 8(15):1440-9. PubMed ID: 19556848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for immunotherapy of cancer.
    Melief CJ; Toes RE; Medema JP; van der Burg SH; Ossendorp F; Offringa R
    Adv Immunol; 2000; 75():235-82. PubMed ID: 10879286
    [No Abstract]   [Full Text] [Related]  

  • 7. Myeloid-derived suppressor cells in cancer: recent progress and prospects.
    Khaled YS; Ammori BJ; Elkord E
    Immunol Cell Biol; 2013 Sep; 91(8):493-502. PubMed ID: 23797066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation in the Tumor Microenvironment.
    Lin Q; Jin S; Han M; Zheng W; Liu J; Wei X
    J Immunol Res; 2018; 2018():1965847. PubMed ID: 30035130
    [No Abstract]   [Full Text] [Related]  

  • 9. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future directions in tumor immunotherapy: CTLA4 blockade.
    Gulley JL; Dahut WL
    Nat Clin Pract Oncol; 2007 Mar; 4(3):136-7. PubMed ID: 17327854
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor immunology top 10 list.
    Finn OJ
    Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cancer immunotherapy: recent breakthroughs and perspectives].
    Tartour E; Sandoval F; Bonnefoy JY; Fridman WH
    Med Sci (Paris); 2011 Oct; 27(10):833-41. PubMed ID: 22027420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting regulatory T cells.
    Ménétrier-Caux C; Curiel T; Faget J; Manuel M; Caux C; Zou W
    Target Oncol; 2012 Mar; 7(1):15-28. PubMed ID: 22327882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and future perspectives of T cell immunotherapy in cancer.
    de Aquino MT; Malhotra A; Mishra MK; Shanker A
    Immunol Lett; 2015 Aug; 166(2):117-33. PubMed ID: 26096822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Tumor Antigens and Cancer Immunotherapy.
    Vigneron N
    Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for pancreatic cancer: current concepts.
    Kaufman HL; Di Vito J; Hörig H
    Hematol Oncol Clin North Am; 2002 Feb; 16(1):159-97, viii. PubMed ID: 12063825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
    Braza MS; Klein B
    Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cancer Research Institute 2013 Annual Symposium: Dynamics of host-tumor interaction.
    Tontonoz M; Gee CE
    Cancer Immunol Res; 2014 Feb; 2(2):105-11. PubMed ID: 24778274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune system and tumors].
    Terme M; Tanchot C
    Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.